[Translated article] Oral Ruxolitinib could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series

MLA

Lasheras-Pérez, M. A., et al. “[Translated Article] Oral Ruxolitinib Could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series.” Actas Dermo-Sifiliográficas, vol. 116, no. 1, Jan. 2025, pp. T110–12. EBSCOhost, https://doi.org/10.1016/j.ad.2024.10.003.

APA

Lasheras-Pérez, M. A., Puebla-Tornero, L., Cañueto, J., de Unamuno-Bustos, B., & Botella-Estrada, R. (2025). [Translated article] Oral Ruxolitinib could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series. Actas Dermo-Sifiliográficas, 116(1), T110–T112. https://doi.org/10.1016/j.ad.2024.10.003

Chicago

Lasheras-Pérez, M.A., L. Puebla-Tornero, J. Cañueto, B. de Unamuno-Bustos, and R. Botella-Estrada. 2025. “[Translated Article] Oral Ruxolitinib Could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series.” Actas Dermo-Sifiliográficas 116 (1): T110–12. doi:10.1016/j.ad.2024.10.003.